Afinitor

Active Ingredient(s): Everolimus
FDA Approved: * March 30, 2009
Pharm Company: * NOVARTIS PHARMS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Afinitor Overview

Everolimus (INN) (/vrolms/) (earlier code name RAD001) is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR). It is currently used as an immunosuppressant to prevent rejection of organ transplants and in the treatment of renal cell cancer and other tumours. Much research has also been conducted on everolimus and other mTOR inhibitors as targeted therapy for use in a number of cancers. It is marketed by No...

Read more Afinitor Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Everolimus

Recent Afinitor Forums: RSS Feed

Renal cell carcinoma and Afinitor

My daughter has stage 4 renal cell carcinoma, the cancer has metastasized to her lungs, lymph nodes and vena cava vein. She has tried both Votrient and Sutent but the cancer has continued to grow. She has seen 3 different surgeons who all agree that surgery is not a option as the risk would far outweigh any benefits. She just started the drug Afinitor and I was wondering if anyone has had positive results with this medication. Know it's not realistic to only look at good postings but she could really use a little positive reinforcement about now. So far she hasn't experienced any severe side effects but if or when they kick in I know she could handle them a lot better if she had a some hope. Any postings would be truly appreciated.

Updated
Afinitor reviews

Can anyone share their experience with taking afinitor, mainly the side effects, especially if you are taking it for neuroendocrine tumors? ## I don't have any personal experience with taking Afinitor (Everolimus), but I thought you might be interested in viewing more side effect related information. You can view this as well as many general details by clicking on the link below: For other detailed information on Everolimus, you can click here: I hope this information helps!

Updated

Possible Dosages for this and Related Drugs:

Everolimus
  • Suspension: 2mg, 3mg, 5mg
  • Tablet: 0.25mg, 0.5mg, 0.75mg, 10mg, 2.5mg, 5mg, 7.5mg
  • Tablet, For Suspension: 2mg, 3mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Afinitor: (7 results)

Sorted by National Drug Code
  • 0078-0566 Afinitor 5 mg Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0567 Afinitor 10 mg Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0594 Afinitor 2.5 mg Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0620 Afinitor 7.5 mg Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0626 Afinitor 0.08 mg/ml Oral Suspension by Novartis Pharmaceuticals Corporation
  • 0078-0627 Afinitor 0.12 mg/ml Oral Suspension by Novartis Pharmaceuticals Corporation
  • 0078-0628 Afinitor 0.2 mg/ml Oral Suspension by Novartis Pharmaceuticals Corporation

Other drugs which contain Everolimus or a similar ingredient: (4 results)

Related Afinitor Topics:

Afinitor reviews
Can anyone share their experience with taking afinitor, mainly the side effects, especially if you are taking it for neu... 1 reply
Renal cell carcinoma and Afinitor
My daughter has stage 4 renal cell carcinoma, the cancer has metastasized to her lungs, lymph nodes and vena cava vein. ...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA